ANI Pharmaceuticals Inc. (ANIP)
NASDAQ: ANIP
· Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
ANI Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 217.8M | 149.8M | 144.86M | 144.98M | 240.11M | 228.6M | 221.12M | 193.08M | 161.71M | 67.76M | 48.23M | 56.28M | 63.38M | 76.91M | 100.3M | 15.25M | 24.26M | 25.07M |
Short-Term Investments | 5.72M | 5.39M | 6.31M | 8.3M | 6.94M | 9.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 2.8M | n/a | n/a | 3.6M | 7.4M | 7.7M | 6.2M | 10M | 9.17M | 6.86M | n/a | 14.38M | 5M | 5M | 5M | 5M | 5M | 5M |
Other Long-Term Assets | 5.45M | 10.31M | 12.22M | 7.86M | 5.75M | 5.87M | 6.07M | 6.07M | 6.46M | 2.37M | 11.36M | 2.73M | 5.76M | 2.43M | 2.21M | 626K | 720K | 833K |
Receivables | 225.65M | 220.33M | 221.73M | 196.36M | 166.09M | 172.42M | 162.08M | 178.84M | 172.93M | 174.71M | 165.44M | 140.43M | 150.41M | 131.63M | 128.53M | 106.71M | 92.65M | 91.88M |
Inventory | 138.31M | 137.41M | 136.78M | 148.04M | 125.45M | 113.84M | 111.2M | 106.59M | 104.32M | 103.65M | 105.36M | 95.89M | 92.55M | 83.16M | 81.69M | 61.68M | 67.63M | 59.93M |
Other Current Assets | 20.86M | 23.36M | 18.01M | 17.51M | 2.87M | 16.05M | 7.82M | 8.22M | 12.31M | 11.96M | 21.41M | 12M | 10.23M | 2.18M | 3.67M | 3.33M | 2.58M | 300K |
Total Current Assets | 602.63M | 536.29M | 527.68M | 521.3M | 555.16M | 540.56M | 519.62M | 497.22M | 459.31M | 364.75M | 344.26M | 309.38M | 322.4M | 301.4M | 321.77M | 191.38M | 191.8M | 182.8M |
Property-Plant & Equipment | 59.25M | 58.18M | 56.86M | 56.7M | 51.64M | 48.53M | 44.59M | 44.19M | 44.37M | 43.27M | 43.25M | 42.83M | 43.77M | 52.71M | 52.67M | 39.53M | 40.33M | 40.77M |
Goodwill & Intangibles | 580.85M | 599.16M | 601.82M | 630.25M | 211.3M | 224.26M | 237.23M | 248.05M | 258.52M | 267.01M | 279.86M | 292.46M | 297.81M | 309.76M | 322.01M | 173.72M | 183.78M | 182.44M |
Total Long-Term Assets | 740.37M | 756.14M | 756.01M | 766.08M | 365.59M | 373.97M | 384.81M | 392.69M | 400.03M | 400.47M | 415.83M | 429.73M | 428.94M | 443.45M | 449.82M | 279.07M | 288.36M | 281.05M |
Total Assets | 1.34B | 1.29B | 1.28B | 1.29B | 920.75M | 914.52M | 904.42M | 889.91M | 859.34M | 765.22M | 760.09M | 739.11M | 751.33M | 744.85M | 771.6M | 470.45M | 480.16M | 463.84M |
Account Payables | 54.57M | 53.06M | 45.66M | 60.89M | 48.68M | 49.43M | 36.68M | 34.08M | 28.5M | 32.69M | 29.3M | 18.99M | 27.64M | 22.06M | 22.97M | 11.51M | 12.98M | 13.77M |
Deferred Revenue | n/a | n/a | n/a | n/a | 2.87M | 11.4M | 8.16M | 75.49M | 4.09M | n/a | n/a | n/a | n/a | 116K | 87K | 62K | 62K | 62K |
Short-Term Debt | 13.22M | 11.19M | 9.17M | 7.15M | 850K | 850K | 850K | 850K | 850K | 850K | 850K | 850K | 850K | 850K | 850K | 15.93M | 15.18M | 14.44M |
Other Current Liabilities | 132.82M | 64.99M | 77.03M | 68.13M | 31.87M | 21.86M | 33.78M | -4.78M | 54.82M | 79.24M | 43.71M | 33.98M | 34.9M | 38.4M | 44.27M | 52.7M | 56.79M | 45.17M |
Total Current Liabilities | 236.84M | 201.81M | 193.68M | 189.93M | 139.98M | 136.89M | 145.48M | 134.35M | 122.86M | 125.83M | 99.44M | 81.63M | 96.31M | 79.53M | 87.54M | 84.87M | 89.45M | 82.77M |
Long-Term Debt | 306.86M | 611.63M | 614.92M | 618.21M | 284.39M | 284.61M | 284.82M | 285.03M | 285.24M | 285.46M | 285.67M | 285.88M | 286.1M | 286.31M | 286.52M | 186.06M | 189.53M | 168.99M |
Other Long-Term Liabilities | 337.7M | 35.51M | 42.02M | 48.44M | 15.77M | 16.21M | 16.53M | 15.82M | 12.03M | 13.26M | 36.44M | 33.45M | 30.97M | 32.05M | 37.81M | 7.93M | 9.04M | 8.13M |
Total Long-Term Liabilities | 644.56M | 647.14M | 661.49M | 666.65M | 300.17M | 325.67M | 301.35M | 300.85M | 302M | 299.92M | 322.11M | 320.81M | 318.06M | 319.22M | 325.32M | 194.18M | 198.79M | 177.36M |
Total Liabilities | 906.24M | 848.96M | 855.17M | 856.58M | 464.99M | 462.56M | 471.67M | 435.2M | 424.87M | 425.74M | 421.55M | 402.44M | 414.38M | 398.75M | 412.86M | 279.05M | 288.24M | 260.13M |
Total Debt | 320.08M | 622.82M | 624.09M | 625.36M | 289.92M | 290.51M | 285.67M | 291.14M | 286.09M | 286.31M | 286.52M | 286.73M | 286.94M | 287.16M | 287.37M | 201.99M | 204.71M | 183.42M |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
Retained Earnings | -76.86M | -85M | -100.28M | -89.6M | -65.03M | -62.33M | -80.13M | -80.88M | -90.41M | -96.25M | -97.29M | -92.64M | -83.63M | -68.3M | -47.77M | -23.44M | -18.99M | -4.89M |
Comprehensive Income | 3.31M | 3.61M | 5.34M | 5.37M | 8.33M | 9.41M | 8.86M | 14.08M | 13.73M | 11.13M | 12.17M | 10.04M | 5.43M | 2.71M | -3.06M | -4.24M | -5.43M | -5.03M |
Shareholders Equity | 436.76M | 443.47M | 428.53M | 430.8M | 480.61M | 476.81M | 457.6M | 454.71M | 434.47M | 339.48M | 338.54M | 336.68M | 336.96M | 346.09M | 358.74M | 191.4M | 191.92M | 203.71M |
Total Investments | 8.52M | 5.39M | 6.31M | 8.3M | 6.94M | 9.65M | 6.2M | 10M | 9.17M | 6.86M | n/a | 14.38M | 5M | 5M | 5M | 5M | 5M | 5M |